Worth Venture Partners’s Cognition Therapeutics CGTX Stock Holding History

Worth Venture Partners’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-508,719	Closed	-$941K	–	88
2023 Q4	$941K	Hold	508,719	–	–	0.51%	63
2023 Q3	$733K	Hold	508,719	–	–	0.44%	63
2023 Q2	$931K	Buy	508,719 +7,000	+1%	+$14.8K	0.51%	54
2023 Q1	$993K	Hold	501,719	–	–	0.49%	56
2022 Q4	$1.05M	Buy	501,719 +301,531	+151%	+$609K	0.63%	50
2022 Q3	$380K	Sell	200,188 -27,982	-12%	-$58.3K	0.24%	86
2022 Q2	$459K	Buy	228,170 +52,804	+30%	+$136K	0.28%	79
2022 Q1	$473K	Buy	+175,366	New	+$676K	0.22%	83

Other funds holding CGTX

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return

Timelo Investment Management Aurora, Ontario, Canada $73M AUM 23.73% 1-Year Est. Return

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

Hohimer Wealth Management Seattle, Washington $818M AUM 29.89% 1-Year Est. Return

Carlson Capital Dallas, Texas $253M AUM 27.64% 1-Year Est. Return

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return